Plico Biotech focuses it research on a diverse array of conditions that share two common features:
– They are caused by a class of proteins that we call Plico Proteins
– The Plico Proteins share a unique pattern of protein folding that goes awry and forms toxic protein aggregates
Plico Proteins contain a unique region that has the property of mediating physiological protein-protein interaction but, at the same time, plays a role in the aberrant and pathological aggregation and accumulation that result in many disorders. Plico Biotech will take advantage of the founders’ new discovery of a molecule that can prevent the formation of the toxic aggregates of Plico Proteins to drive drug discovery and develop novel medications.